Mycoplasma pneumoniae infections in childhood

Pediatric Infectious Disease Journal

Volumn 33, Issue 1, 2014, Pages 92-94

  Atkinson, T Prescott ^a   Waites, Ken B ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC RESISTANCE; ARTICLE; ASTHMA; COMMUNITY ACQUIRED PNEUMONIA; DIAGNOSTIC PROCEDURE; HUMAN; IMMUNE RESPONSE; MYCOPLASMA PNEUMONIA; MYCOPLASMA PNEUMONIAE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL;

ADOLESCENT; ASTHMA; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; MYCOPLASMA INFECTIONS; MYCOPLASMA PNEUMONIAE;

EID: 84891502706     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000000171     Document Type: Article

References (14)

1. Gadsby NJ, Reynolds AJ, McMenamin J, et al. Increased reports of Mycoplasma pneumoniae from laboratories in Scotland in 2010 and 2011 -Impact of the epidemic in infants. Euro Surveill. 2012;17:pii=20110
2. Wang K, Gill P, Perera R, et al. Clinical symptoms and signs for the diagnosis of Mycoplasma pneumoniae in children and adolescents with community-acquired pneumonia. Cochrane Database Syst Rev. 2012;10:CD009175
3. Kannan TR, Baseman JB. ADP-ribosylating and vacuolating cytotoxin of Mycoplasma pneumoniae represents unique virulence determinant among bacterial pathogens. Proc Natl Acad Sci USA. 2006;103:6724-6729
4. Techasaensiri C, Tagliabue C, Cagle M, et al. Variation in colonization, ADP-ribosylating and vacuolating cytotoxin, and pulmonary disease severity among Mycoplasma pneumoniae strains. Am J Respir Crit Care Med. 2010;182:797-804
5. Waites KB, Balish MF, Atkinson TP. New insights into the pathogenesis and detection of Mycoplasma pneumoniae infections. Future Microbiol. 2008;3:635-648
6. Martin RJ, Kraft M, Chu HW, et al. A link between chronic asthma and chronic infection. J Allergy Clin Immunol. 2001;107:595-601
7. Sutherland ER, King TS, Icitovic N, et al.; National Heart, Lung and Blood Institute's Asthma Clinical Research Network. A trial of clarithromycin for the treatment of suboptimally controlled asthma. J Allergy Clin Immunol. 2010;126:747-753
8. Peters J, Singh H, Brooks EG, et al. Persistence of community-acquired respiratory distress syndrome toxin-producing Mycoplasma pneumoniae in refractory asthma. Chest. 2011;140:401-407
9. Wood PR, Hill VL, Burks ML, et al. Mycoplasma pneumoniae in children with acute and refractory asthma. Ann Allergy Asthma Immunol. 2013;110:328-334.e1
10. W aites KB. What's new in diagnostic testing and treatment approaches for Mycoplasma pneumoniae infections in children? Adv Exp Med Biol. 2011;719:47-57
11. Waites KB, Taylor-Robinson D. Mycoplasma and ureaplasma. In: Versalovic J, Carrolol K, Funke G, et al, eds. Manual of Clinical Microbiology, 10th Ed. Washington, D.C.: ASM Press; 2011:970-985
12. Ozaki T, Nishimura N, Ahn J, et al. Utility of a rapid diagnosis kit for Mycoplasma pneumoniae pneumonia in children, and the antimicrobial susceptibility of the isolates. J Infect Chemother. 2007;13:204-207
13. T ouati A, Benard A, Hassen AB, et al. Evaluation of five commercial real-time PCR assays for detection of Mycoplasma pneumoniae in respiratory tract specimens. J Clin Microbiol. 2009;47:2269-2271
14. Li X, Atkinson TP, Hagood J, et al. Emerging macrolide resistance in Mycoplasma pneumoniae in children: Detection and characterization of resistant isolates. Pediatr Infect Dis J. 2009;28:693-696